Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-06-30
1976-07-27
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260559B, A01N 920, C07C10319
Patent
active
039718506
ABSTRACT:
Miticidally active compounds are described herein, which are defined by the generic formula ##SPC1##
Wherein X is either fluorine or trifluoromethyl; Y is either hydrogen or chlorine; R.sup.1 is either methyl or ethyl; and where X is fluorine, R.sup.2 is hydrogen and R.sup.3 is methyl; and where X is trifluoromethyl, R.sup.2 and R.sup.3 are independently either hydrogen or methyl.
REFERENCES:
patent: 2426885 (1947-09-01), Kilgore
patent: 3557209 (1971-01-01), Richter et al.
Baker Don R.
Walker Francis H.
Bradley Michael J.
Schenkman Leonard
Stauffer Chemical Company
LandOfFree
N-substituted-N-(1-substituted-1-methyl-2-propynyl)-.alpha.-(sub does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted-N-(1-substituted-1-methyl-2-propynyl)-.alpha.-(sub, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted-N-(1-substituted-1-methyl-2-propynyl)-.alpha.-(sub will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1625074